CPTAC Uterine Corpus Endometrial Carcinoma Baseline Form

Preferred Label : CPTAC Uterine Corpus Endometrial Carcinoma Baseline Form;

NCI Metathesaurus CUI : CL951271;

Details

Origin ID

C159413;

UMLS CUI

C5204411;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
subset_includes_concept
- AJCC Cancer Staging Manual 7th Edition [NCIt concept]
- AJCC Cancer Staging Manual 8th Edition [NCIt concept]
- Additional Immunohistochemistry Was Not Performed [NCIt concept]
- Additional Immunohistochemistry Was Performed [NCIt concept]
- Additional Pathologic Findings [NCIt concept]
- Additional Testing Was Not Performed [NCIt concept]
- Additional Testing Was Performed [NCIt concept]
- Ancillary Study [NCIt concept]
- Anterior Endometrium [NCIt concept]
- Ascites Fluid Sample [NCIt concept]
- At Time of Diagnosis [NCIt concept]
- Atypical Peritoneal Fluid [NCIt concept]
- CDR Entry Completed by (signature) [NCIt concept]
- CPTAC Case Identifier [NCIt concept]
- Carcinoma Exhibiting Undifferentiated or Dedifferentiated Features [NCIt concept]
- Cellular Tumor Antigen p53 [NCIt concept]
- Centimeter [NCIt concept]
- Complex Endometrial Hyperplasia [NCIt concept]
- Complex Endometrial Hyperplasia without Atypia [NCIt concept]
- Confirm AJCC/TNM Cancer Staging Edition [NCIt concept]
- Current Oral Contraceptive User [NCIt concept]
- Current User Tamoxifen [NCIt concept]
- Currently Using Menopausal Hormone Therapy [NCIt concept]
- DNA Mismatch Repair Protein Mlh1 [NCIt concept]
- DNA Mismatch Repair Protein Msh2 [NCIt concept]
- DNA Mismatch Repair Protein Msh6 [NCIt concept]
- Donor Information [NCIt concept]
- ECOG Performance Status 0 [NCIt concept]
- ECOG Performance Status 1 [NCIt concept]
- ECOG Performance Status 2 [NCIt concept]
- ECOG Performance Status 3 [NCIt concept]
- ECOG Performance Status 4 [NCIt concept]
- ECOG Performance Status not Evaluated, not Provided or Available [NCIt concept]
- End Date [NCIt concept]
- Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia [NCIt concept]
- Endometrial Clear Cell Adenocarcinoma [NCIt concept]
- Endometrial Hyperplasia [NCIt concept]
- Endometrial Mixed Cell Adenocarcinoma [NCIt concept]
- Endometrioid Adenocarcinoma [NCIt concept]
- Estrogen Receptor Negative [NCIt concept]
- Estrogen Receptor Positive [NCIt concept]
- Estrogen Receptor Status [NCIt concept]
- Form Completed by (Signature) [NCIt concept]
- Former Oral Contraceptive User [NCIt concept]
- Former User Tamoxifen [NCIt concept]
- Formerly Used Menopausal Hormone Therapy [NCIt concept]
- Fundus Uteri [NCIt concept]
- Greater than or Equal to 50% Myometrial Invasion [NCIt concept]
- Greater than or equal to Four Pregnancies [NCIt concept]
- Greatest Dimension Tumor [NCIt concept]
- Have Oral Contraceptives Ever Been Taken [NCIt concept]
- High-Frequency Microsatellite Instability [NCIt concept]
- Histologic Grade for Other Carcinomas [NCIt concept]
- Histologic Type [NCIt concept]
- IHC Staining not Done [NCIt concept]
- If Other Edition, Specify [NCIt concept]
- Incomplete Staging (cM) [NCIt concept]
- Incomplete Staging (pM) [NCIt concept]
- Indeterminate [NCIt concept]
- Indeterminate Microsatellite Instability [NCIt concept]
- Initial Cancer Diagnosis Date [NCIt concept]
- Is Myometrial Invasion Present [NCIt concept]
- Is Paraneoplastic Syndrome Present [NCIt concept]
- Is Tumor Cell Necrosis Present [NCIt concept]
- Karnofsky Performance Status 0 [NCIt concept]
- Karnofsky Performance Status 10 [NCIt concept]
- Karnofsky Performance Status 100 [NCIt concept]
- Karnofsky Performance Status 20 [NCIt concept]
- Karnofsky Performance Status 30 [NCIt concept]
- Karnofsky Performance Status 40 [NCIt concept]
- Karnofsky Performance Status 50 [NCIt concept]
- Karnofsky Performance Status 60 [NCIt concept]
- Karnofsky Performance Status 70 [NCIt concept]
- Karnofsky Performance Status 80 [NCIt concept]
- Karnofsky Performance Status 90 [NCIt concept]
- Karnofsky Performance Status Not Evaluated [NCIt concept]
- Karnofsky Performance Status Unknown [NCIt concept]
- Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Less than 50% Myometrial Invasion [NCIt concept]
- Low-Frequency Microsatellite Instability [NCIt concept]
- MLH1 Gene Promoter Hypermethylation [NCIt concept]
- MLH1 Gene Promoter Hypermethylation Negative [NCIt concept]
- MLH1 Gene Promoter Hypermethylation Status [NCIt concept]
- MLH1 Loss of Nuclear Expression [NCIt concept]
- MLH1 Nuclear Expression Intact [NCIt concept]
- MSH2 Loss of Nuclear Expression [NCIt concept]
- MSH2 Nuclear Expression Intact [NCIt concept]
- MSH6 Loss of Nuclear Expression [NCIt concept]
- MSH6 Nuclear Expression Intact [NCIt concept]
- Margin Involved by Invasive Carcinoma [NCIt concept]
- Margin Status Cannot be Assessed [NCIt concept]
- Margin Uninvolved by Invasive Carcinoma [NCIt concept]
- Menopause Status [NCIt concept]
- Microsatellite Instability [NCIt concept]
- Microsatellite Stable [NCIt concept]
- Mismatch Repair Endonuclease PMS2 [NCIt concept]
- Moderately Differentiated [NCIt concept]
- Month-Day-Year [NCIt concept]
- Month-Year [NCIt concept]
- Multifocal Lesion [NCIt concept]
- Myometrial Invasion [NCIt concept]
- Myometrial Invasion Not Identified [NCIt concept]
- Never Used Menopausal Hormone Therapy [NCIt concept]
- Never Used Oral Contraceptives [NCIt concept]
- Never Used Tamoxifen [NCIt concept]
- No Evidence of Tumor Cell Necrosis Present [NCIt concept]
- No Pathologic Evidence of Distant Metastasis [NCIt concept]
- No Pathologic Findings Identified [NCIt concept]
- Not Known if Additional Immunohistochemistry Was Performed [NCIt concept]
- Number of Full Term Pregnancies [NCIt concept]
- Number of Other Lymph Nodes Examined [NCIt concept]
- Number of Other Lymph Nodes Positive for Tumor by H&E [NCIt concept]
- Number of Other Lymph Nodes Positive for Tumor by IHC staining only [NCIt concept]
- Number of Para-aortic Lymph Nodes Examined [NCIt concept]
- Number of Para-aortic Lymph Nodes Positive for Tumor by H&E [NCIt concept]
- Number of Para-aortic Lymph Nodes Positive for Tumor by IHC Staining Only [NCIt concept]
- Number of Pelvic Lymph Nodes Examined [NCIt concept]
- Number of Pelvic Lymph Nodes Positive for Tumor by H&E [NCIt concept]
- Number of Pelvic Lymph Nodes Positive for Tumor by IHC staining only [NCIt concept]
- One Full Term Pregnancy [NCIt concept]
- Organ of Origin [NCIt concept]
- Other Edition [NCIt concept]
- Other Histologic Grade [NCIt concept]
- Other Histologic Type [NCIt concept]
- Other Pathologic Findings [NCIt concept]
- Other Tumor Site [NCIt concept]
- Ovarian Mucinous Adenocarcinoma [NCIt concept]
- Ovarian Serous Adenocarcinoma [NCIt concept]
- PMS2 Loss of Nuclear Expression [NCIt concept]
- PMS2 Nuclear Expression Intact [NCIt concept]
- Paraneoplastic Syndrome Status is Unknown [NCIt concept]
- Paraneoplastic Syndrome is Not Present [NCIt concept]
- Paraneoplastic Syndrome is Present [NCIt concept]
- Perimenopausal 6 to 12 Months Since LMP [NCIt concept]
- Peritoneal Fluid Not Examined [NCIt concept]
- Peritoneal Fluid Positive for Malignancy [NCIt concept]
- Peritoneal Fluid is Negative for Malignancy [NCIt concept]
- Poorly Differentiated [NCIt concept]
- Posterior Endometrium [NCIt concept]
- Postmenopausal with no Prior Oophorectomy Status [NCIt concept]
- Premenopausal Greater than 6 months since LMP and no Prior Bilateral Oophorectomy and Not on Estrogen Replacement [NCIt concept]
- Preoperative ECOG - Performance Status [NCIt concept]
- Preoperative Karnofsky Performance Status [NCIt concept]
- Print, Sign, Date Form [NCIt concept]
- Progesterone Receptor Negative [NCIt concept]
- Progesterone Receptor Positive [NCIt concept]
- Progesterone Receptor Status [NCIt concept]
- Residual Disease [NCIt concept]
- Select All That Apply [NCIt concept]
- Select Histologic Type [NCIt concept]
- Select One [NCIt concept]
- Simple Endometrial Hyperplasia [NCIt concept]
- Simple Endometrial Hyperplasia without Atypia [NCIt concept]
- Site of Tumor [NCIt concept]
- Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Specify [NCIt concept]
- Specify Other Histologic Grade [NCIt concept]
- Specify Other Histologic Type [NCIt concept]
- Specify Other Tumor Site [NCIt concept]
- Specify Site if Documented Distant Metastasis [NCIt concept]
- Specify Type of Testing and Results if Yes [NCIt concept]
- Specify if Present [NCIt concept]
- Stage I Uterine Corpus Cancer AJCC v8 [NCIt concept]
- Stage II Uterine Corpus Cancer AJCC v8 [NCIt concept]
- Stage III Uterine Corpus Cancer AJCC v8 [NCIt concept]
- Stage IV Uterine Corpus Cancer AJCC v8 [NCIt concept]
- Start Date [NCIt concept]
- Surgical Margins Status [NCIt concept]
- TP53 Loss of Nuclear Expression [NCIt concept]
- TP53 Nuclear Expression Intact [NCIt concept]
- Three Full Term Pregnancies [NCIt concept]
- Tissue Source Site [NCIt concept]
- Tissue Source Site Identifier [NCIt concept]
- Transcribe Data into CDR and Record the Following [NCIt concept]
- Tumor Cell Necrosis is Present [NCIt concept]
- Tumor Focality [NCIt concept]
- Two Full Term Pregnancies [NCIt concept]
- Unifocal Lesion [NCIt concept]
- Unknown ECOG Performance Status [NCIt concept]
- Unknown Number of Full Term Pregnancies [NCIt concept]
- Unknown Tamoxifen Use [NCIt concept]
- Unknown Use of Menopausal Hormone Therapy [NCIt concept]
- Uterine Corpus Cancer by AJCC v8 Stage [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma Clinical Distant Metastasis TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma Pathologic Distant Metastasis TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma Pathologic Primary Tumor TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma Pathologic Regional Lymph Nodes TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma cM0 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma cM1 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pM1 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pN0 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pN1 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pN2 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pNX TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT0 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT1 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT1a TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT1b TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT2 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT3a TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT3b TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pT4 TNM Finding v8 [NCIt concept]
- Uterine Corpus Carcinoma and Carcinosarcoma pTX TNM Finding v8 [NCIt concept]
- Was Additional Immunohistochemical Testing Performed [NCIt concept]
- Was Additional Testing Performed [NCIt concept]
- Was Menopausal Hormone Therapy Ever Used [NCIt concept]
- Was Tamoxifen Ever Taken [NCIt concept]
- Well Differentiated [NCIt concept]
- Zero Full Term Pregnancies [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients